Posts

Showing posts from March, 2021

COVID-19 Diagnostics Market Report to observe Potential Impact of Coronavirus (COVID19), Industry Dynamics and Future Growth

  Market Overview MRFR (Market Research Future) confirms that the COVID-19 diagnostics market 2020 can record a growth rate of 6.28% between 2021 and 2027 (analysis period). The market size will most likely touch USD 96,293.9 Million by 2027. The rampant growth in the number of SARS-CoV-2 cases is fostering the need for COVID-19 diagnostics, and remains the prime reason behind the strong market growth, affirms MRFR. Request Sample Copy: https://www.marketresearchfuture.com/sample_request/9710 Top Drivers and Barriers While the recovery rate following the COVID-19 outbreak has been promising, the pandemic has still caused severe illnesses among elderly patients or people with underlying ailments like cancer and diabetes. The death rate due to the novel coronavirus has been significantly high, bolstering the need for accurate and effective diagnostic methods. As of now, more than 600 SARS-CoV-2 diagnostic tests have been approved while some are still being developed by the manufacturers.

Remdesivir (COVID 19) Market Research in-Depth Analysis, Key Players, Challenges, Segmentation and Forecasts

  Market Highlights Remdesivir is an antiviral drug. FDA approved the remdesivir drug in April 2020 for the clinical trials for COVID 19 treatment. Studies have shown that around 46% of US patients have been recovered from COVID 19 quickly. According to MRFR analysis, Global Remdesivir (COVID 19) Market is expected to register a CAGR of 31.2% during the forecast period of 2020 to 2027 and reach USD 10,119.99 Million by 2027. Request Sample Copy: https://www.marketresearchfuture.com/sample_request/10141 The growth of the global Remdesivir (COVID 19) market can be contributed to the growing need for rescue medication, including remdesivir drugs, due to the outbreak of COVID-19globally. Furthermore, the rising geriatric population is also expected to fuel market growth during the forecast period. However, the availability of various substitutes for Remdesivir (COVID 19), are expected to restrain the growth of the global Remdesivir (COVID 19) market. Gilead Sciences, Inc., Bright Gene, Hai

Somatostatin Analogs Market with Potential Impact of Coronavirus (COVID19), SWOT Analysis, Risk Analysis, and Forecast

  Market Scope Somatostatin analogs market 2020 can expect to capture a significant valuation of close to USD 8,640 Million by 2025, reveals MRFR (Market Research Future). MRFR also projects favorable prospects for the market at a CAGR of 6.8% between 2019 and 2025 (assessment period). We will provide COVID-19 impact analysis with the report, combined with an in-depth analysis following the coronavirus disease outbreak. Request Sample Copy: https://www.marketresearchfuture.com/sample_request/8633 Main Drivers and Deterrents The American Association of Neurological Surgeons’ latest study reveals that close to 10-15 per million cases of Cushing’s syndrome emerge each year. The syndrome is commonly known to affect individuals in the age group of 20 to 50 years and is more prominent among the female population. Apart from this, the rising prevalence of NETs/neuroendocrine tumors has also been observed worldwide, in recent years. Estimations reveal that in the US alone, over 12,000 patients

Biomarkers Market Increasing Rapidly: Covid-19 Impacts, Industry Opportunity, Analysis and Forecast

  Market’s Viewpoint The Global Biomarkers Market 2020 shares are rising as the COVID 19 pandemic destabilizes other markets that struggle with the closure of businesses globally. This compulsion during a time of isolation, job loss, and stress is witnessed to be more, according to data collected by Market Research Future experts. Yet, the Biomarkers Market is expected to garner revenue of USD 4,582.8 Million by 2027, while soaring at 10.28% through the years 2020 to 2027—the forecast period. Request Sample Copy: https://www.marketresearchfuture.com/sample_request/1941 Biomarkers Market—Boomers & Decliners The biomarkers market worldwide is on the growth path, thanks to the ever-increasing use of biomarkers in the field of medicine. Biomarkers also offer tremendous support for efficient clinical decision making, which is mainly dependent on diagnosing the health status of a patient. Biomarkers are progressively finding application in the diagnosis of various diseases, especially ca

Doppler Ultrasound Market Trends and Demand, Analysis, Key Vendors, Regions, Type, Application and Forecast 

  Market Synopsis: Market Research Future (MRFR)’s latest study reveals that the global bone graft substitutes market is expected to expand at 6.52% CAGR during the forecast period 2017 to 2027. The market is set to reach a valuation of USD 5,031 Mn by the end of the assessment period. The increasing prevalence of diseases related to bones has intensified the demand for bone graft substitutes. Request Sample Copy: https://www.marketresearchfuture.com/sample_request/1195 The painful procedure related to autografts have paved the way for developments in the bone graft substitutes market. Hence, the demand for alternatives such as allografts, xenografts, and synthetic bone grafts has been on the rise. It is projected to aid the proliferation of the market in the forthcoming years by accelerating its adoption. The growth of the bone graft substitutes market is guided by the factors such as increasing orthopedic problems, exponential geriatric population, and rising demand for reconstructiv